Komori
Tokai Rika (6995) · InitiativeAdvanced

Expansion of R&D Investment

First written in FY2016. 16 of 34 entries say "Restated". Latest entry: FY2026.

34entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2022-Q3 – FY2024-Q2AdvancedFY2024 – FY20262016: 320162017: 420172018: 420182019: 420192020: 420202021: 320212022: 420222023: 320232024: 320242025: 120252026: 12026
Same theme, other companies
R&D and Commercialization of Components for Automotive and Housing ApplicationsA theme 12 companies write about · 0 as a headwind · 12 as a tailwind

9 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「As a result, total research and development expenses for the current consolidated fiscal year amounted to ¥34,421 million.」

    Research and development expenses increased from ¥30,505 million in the previous fiscal year to ¥34,421 million, and development areas have also expanded to include Hidden Switch, next-generation standard retractors, digital keys, and semiconductors.
  2. FY2026-H1AdvancedAnnual report

    「The amount spent on research and development activities across the Group during the current interim consolidated accounting period was ¥16,038 million.」

    Research and development expenses increased from ¥14,981 million in the same period of the previous year to ¥16,038 million. The company states that there were no material changes in the status of its research and development activities.
  3. FY2025-H1AdvancedAnnual report

    「The amount spent on research and development activities across the Group during the current interim consolidated accounting period was ¥14,981 million.」

    Research and development expenses increased from ¥14,227 million in the same period of the previous year to ¥14,981 million. At the same time, the company states that there were no material changes in the status of its research and development activities.
  4. FY2024AdvancedAnnual report

    「As a result, total research and development expenses for the current consolidated fiscal year amounted to ¥30,505 million.」

    Research and development expenses increased from ¥30,470 million in the previous fiscal year to ¥30,505 million. Development areas have also expanded to include HMI, shift-by-wire, digital keys, and consumer products.
  5. FY2024-Q3SoftenedAnnual report

    「The amount spent on research and development activities across the Group during the cumulative third quarter of the current consolidated fiscal year was ¥21,794 million. There were no material changes in the status of the Group's research and development activities during the cumulative third quarter of the current consolidated fiscal year.」

    Research and development expenses decreased from ¥22,617 million in the same quarter of the previous year to ¥21,794 million. At the same time, the company states that there were no material changes in the status of its research and development activities.
  6. FY2024-Q2AdvancedAnnual report

    「The amount spent on research and development activities across the Group during the cumulative second quarter of the current consolidated fiscal year was ¥14,467 million. There were no material changes in the status of the Group's research and development activities during the cumulative second quarter of the current consolidated fiscal year.」

    Research and development expenses increased by ¥240 million from ¥14,227 million in the same quarter of the previous year to ¥14,467 million. The company states that there were no material changes in the status of its research and development activities.
  7. FY2024-Q1AdvancedAnnual report

    「The amount spent on research and development activities across the Group during the cumulative first quarter of the current consolidated fiscal year was ¥6,749 million. There were no material changes in the status of the Group's research and development activities during the cumulative first quarter of the current consolidated fiscal year.」

    Research and development expenses increased from ¥6,640 million in the same period of the previous year to ¥6,749 million. At the same time, the company states that there were no material changes in the status of its research and development activities.
  8. FY2023-Q3AdvancedAnnual report

    「The amount spent on research and development activities across the Group during the cumulative third quarter of the current consolidated fiscal year was ¥22,617 million.」

    Research and development expenses increased from ¥22,143 million in the same quarter of the previous year to ¥22,617 million. At the same time, the company states that there were no material changes in the status of its research and development activities.
  9. FY2023-Q2AdvancedAnnual report

    「The amount spent on research and development activities across the Group during the cumulative second quarter of the current consolidated fiscal year was ¥14,651 million. There were no material changes in the status of the Group's research and development activities during the cumulative second quarter of the current consolidated fiscal year.」

    Research and development expenses increased from ¥14,227 million in the same quarter of the previous year to ¥14,651 million, confirming an increase in research and development investment.
  10. FY2023-Q1AdvancedAnnual report

    「The amount spent on research and development activities across the Group during the cumulative first quarter of the current consolidated fiscal year was ¥7,165 million.」

    Research and development expenses increased from ¥6,640 million in the same period of the previous year to ¥7,165 million. At the same time, the company states that there were no material changes in the status of its research and development activities.
  11. FY2022AdvancedAnnual report

    「As a result, total research and development expenses for the current consolidated fiscal year amounted to ¥30,470 million.」

    Research and development expenses increased from ¥28,119 million in the previous fiscal year to ¥30,470 million. Development areas have also become more specific, including new products, digital keys, and EV and autonomous driving-related technologies.
  12. FY2022-Q3AdvancedAnnual report

    「The amount spent on research and development activities across the Group during the cumulative third quarter of the current consolidated fiscal year was ¥22,143 million. There were no material changes in the status of the Group's research and development activities during the cumulative third quarter of the current consolidated fiscal year.」

    Research and development expenses increased from ¥20,063 million in the same quarter of the previous year to ¥22,143 million, confirming an increase in research and development investment. At the same time, the company states that there were no material changes in the status of its research and development activities.
  13. FY2022-Q2RestatedAnnual report

    「The amount spent on research and development activities across the Group during the cumulative second quarter of the current consolidated fiscal year was ¥14,227 million. There were no material changes in the status of the Group's research and development activities during the cumulative second quarter of the current consolidated fiscal year.」

    The company disclosed research and development expenses of ¥14,227 million and reaffirmed that there were no material changes in the status of its research and development activities.
  14. FY2022-Q1RestatedAnnual report

    「The amount of R&D activity across the group during the first-quarter cumulative consolidated period was ¥6,640 million. There were no material changes in the status of the group's R&D activities during the first-quarter cumulative consolidated period.」

    Discloses first-quarter R&D expenses of ¥6,640 million, an increase from ¥6,511 million in the same period of the previous year, while explicitly stating that there were no material changes in the status of R&D activities.
  15. FY2021-Q3SoftenedAnnual report

    「The amount of R&D activity across the group during the third-quarter cumulative consolidated period was ¥20,063 million. There were no material changes in the status of the group's R&D activities during the third-quarter cumulative consolidated period.」

    While stating that there were no material changes in the status of R&D activities, the company reports that R&D expenses decreased from ¥20,459 million in the same period of the previous year to ¥20,063 million.
  16. FY2021-Q2RestatedAnnual report

    「The amount of R&D activity across the group during the second-quarter cumulative consolidated period was ¥13,514 million. There were no material changes in the status of the group's R&D activities during the second-quarter cumulative consolidated period.」

    Discloses R&D expenses of ¥13,514 million and reconfirms that there were no material changes in the status of R&D activities.
  17. FY2021-Q1RestatedAnnual report

    「The amount of R&D activity across the group during the first-quarter cumulative consolidated period was ¥6,511 million. There were no material changes in the status of the group's R&D activities during the first-quarter cumulative consolidated period.」

    Discloses first-quarter R&D expenses of ¥6,511 million and states explicitly that there were no material changes in the status of R&D activities.
  18. FY2020AdvancedAnnual report

    「As a result, total research and development expenses for the fiscal year under review amounted to ¥28,119 million.」

    R&D expenses increased from ¥25,856 million in the previous fiscal year to ¥28,119 million. The areas of development have also expanded to include digital keys, digitalization and miniaturization, and safety systems.
  19. FY2020-Q3RestatedAnnual report

    「The amount of R&D activity across the group during the third-quarter cumulative consolidated period was ¥20,459 million. There were no material changes in the status of the group's R&D activities during the third-quarter cumulative consolidated period.」

    Discloses third-quarter cumulative R&D expenses of ¥20,459 million and reconfirms that there were no material changes in the status of R&D activities.
  20. FY2020-Q2RestatedAnnual report

    「The amount of R&D activity across the group during the second-quarter cumulative consolidated period was ¥13,239 million. There were no material changes in the status of the group's R&D activities during the second-quarter cumulative consolidated period.」

    Discloses R&D expenses of ¥13,239 million and states explicitly that there were no material changes in the status of R&D activities.
  21. FY2020-Q1RestatedAnnual report

    「The amount of R&D activity across the group during the first-quarter cumulative consolidated period was ¥6,176 million. There were no material changes in the status of the group's R&D activities during the first-quarter cumulative consolidated period.」

    Recognized R&D expenses of ¥6,176 million and states explicitly that there were no material changes in the status of R&D activities.
  22. FY2019AdvancedAnnual report

    「As a result, total research and development expenses for the fiscal year under review amounted to ¥25,856 million.」

    R&D expenses increased from ¥25,398 million in the previous fiscal year to ¥25,856 million.
  23. FY2019-Q3RestatedAnnual report

    「The amount of R&D activity across the group during the third-quarter cumulative consolidated period was ¥18,991 million. There were no material changes in the status of the group's R&D activities during the third-quarter cumulative consolidated period.」

    Discloses R&D expenses of ¥18,991 million and states explicitly that there were no material changes in the status of R&D activities.
  24. FY2019-Q2RestatedAnnual report

    「The amount of R&D activity across the group during the second-quarter cumulative consolidated period was ¥12,497 million. There were no material changes in the status of the group's R&D activities during the second-quarter cumulative consolidated period.」

    Discloses R&D expenses of ¥12,497 million and states explicitly that there were no material changes in the status of R&D activities.
  25. FY2019-Q1RestatedAnnual report

    「The amount of R&D activity across the group during the first-quarter cumulative consolidated period was ¥5,950 million. There were no material changes in the status of the group's R&D activities during the first-quarter cumulative consolidated period.」

    Discloses R&D expenses of ¥5,950 million and states explicitly that there were no material changes in the status of R&D activities.
  26. FY2018SoftenedAnnual report

    「As a result, total research and development expenses for the fiscal year under review amounted to ¥25,398 million.」

    R&D activities have continued, but R&D expenses decreased from ¥25,669 million in the previous fiscal year to ¥25,398 million. The company also describes efforts related to commercialization and mass production, as well as electrification, digitalization and intelligent systems.
  27. FY2018-Q3RestatedAnnual report

    「The amount of R&D activity across the group during the third-quarter cumulative consolidated period was ¥18,939 million. There were no material changes in the status of the group's R&D activities during the third-quarter cumulative consolidated period.」

    Discloses R&D expenses of ¥18,939 million and states explicitly that there were no material changes in the status of R&D activities.
  28. FY2018-Q2RestatedAnnual report

    「The amount of R&D activity across the group during the second-quarter cumulative consolidated period was ¥12,657 million. There were no material changes in the status of the group's R&D activities during the second-quarter cumulative consolidated period.」

    Although cumulative R&D expenses of ¥12,657 million were disclosed, the company explicitly states that there were no material changes in the status of R&D activities.
  29. FY2018-Q1RestatedAnnual report

    「The amount of R&D activity across the group during the first-quarter cumulative consolidated period was ¥6,086 million. There were no material changes in the status of the group's R&D activities during the first-quarter cumulative consolidated period.」

    Discloses R&D expenses of ¥6,086 million and states explicitly that there were no material changes in the status of R&D activities.
  30. FY2017AdvancedAnnual report

    「As a result, total research and development expenses for the fiscal year under review amounted to ¥25,669 million.」

    R&D expenses increased from ¥25,006 million in the previous fiscal year to ¥25,669 million. The company also lists mass production and advanced development by product area.
  31. FY2017-Q3RestatedAnnual report

    「The amount of R&D activity across the group during the third-quarter cumulative consolidated period was ¥18,965 million. There were no material changes in the status of the group's R&D activities during the third-quarter cumulative consolidated period.」

    Discloses cumulative R&D expenses of ¥18,965 million and states explicitly that there were no material changes in the status of R&D activities.
  32. FY2017-Q2RestatedAnnual report

    「The amount of R&D activity across the group during the second-quarter cumulative consolidated period was ¥12,551 million. There were no material changes in the status of the group's R&D activities during the second-quarter cumulative consolidated period.」

    Discloses cumulative R&D expenses of ¥12,551 million and states explicitly that there were no material changes in the status of R&D activities.
  33. FY2017-Q1RestatedAnnual report

    「The amount of R&D activity across the group during the first-quarter cumulative consolidated period was ¥6,185 million. There were no material changes in the status of the group's R&D activities during the first-quarter cumulative consolidated period.」

    Discloses quarterly R&D expenses of ¥6,185 million and states explicitly that there were no material changes in the status of R&D activities.
  34. FY2016First statedAnnual report

    「As a result, total research and development expenses for the fiscal year under review amounted to ¥25,006 million.」

    Shows the current fiscal year's R&D expenses for the development of automotive switches, input devices, shift levers, security systems, safety systems and other products.
Moved together

"Product Warranty Costs Arising from Quality Issues and Their Impact on Earnings" moved the same way as this thread, in the same document, in 8 of its 34 moves.

886665★123456
  1. ★This thread
  2. 1Product Warranty Costs Arising from Quality Issues and Their Impact on Earnings8×
  3. 2Strengthening Customer Responsiveness through the Expansion of Sales Offices8×
  4. 3Dependence on Sales to the Automotive Industry and Toyota Motor Corporation6×
  5. 4Preventing Recurrence of Serious Defects and Strengthening the Quality Assurance Framework6×
  6. 5Development of Next-Generation and New Products6×
  7. 6Quality issues, including recalls5×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Tokai Rika yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.